Index 929
development and course of, 454–456
in association with a disorder of sex 
development, 456
without a disorder of  sex development, 
455–456
diagnostic criteria for, 452–453
diagnostic features of, 453–454
diagnostic markers for, 457
differential diagnosis of, 458
functional consequences of, 457–458
highlights of changes fr om DSM-IV to DSM-5, 
814–815
other specified, 459
prevalence of, 454
risk and prognostic factors for, 456–457
specifiers for, 453
unspecified, 459
Generalized anxiety disorder, 190, 222–226
associated features supporting diagnosis of, 223
comorbidity with, 226
culture-related diagnostic issues in, 224
development and course of, 223–224
diagnostic criteria for, 222
diagnostic features of, 222–223
differential diagnosis of, 225–226
functional consequences of, 225
gender-related diagnostic issues in, 224–225
prevalence of, 223
risk and prognostic factors for, 224
Genito-pelvic pain/penetration disorder, 423, 
437–440
associated features supporting diagnosis of, 
438
comorbidity with, 440
culture-related diagnostic issues in, 439
development and course of, 439
diagnostic criteria for, 437
diagnostic features of, 437–438
differential diagnosis of, 440
functional consequences of, 439
gender-related diagnostic issues in, 439
prevalence of, 438
risk and prognostic factors for, 439
Global Assessment of Functioning (GAF) scale, 16
Global developmental delay, 31, 41